Effect of cibenzoline, a class Ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy

Cardiovascular Drugs and Therapy

Volumn 15, Issue 5, 2001, Pages 459-465

  Kondo, Isao ^a   Mizushige, Katsufumi ^a   Nozaki, Shiro ^a   Iwado, Yasuyoshi ^a   Masugata, Hisashi ^a   Kohno, Masakazu ^a   Matsuo, Hirohide ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Bisoprolol; Cibenzoline; Diastolic function; Doppler echocardiography; Hypertrophic obstructive cardiomyopathy

Indexed keywords

ANTIARRHYTHMIC AGENT; BISOPROLOL; CIBENZOLINE;

ARTICLE; CALCULATION; CLINICAL ARTICLE; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART AFTERLOAD; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; M MODE ECHOCARDIOGRAPHY; MALE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; AGED; ANTI-ARRHYTHMIA AGENTS; BISOPROLOL; BLOOD FLOW VELOCITY; CARDIOMYOPATHY, HYPERTROPHIC; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; VENTRICULAR FUNCTION, LEFT; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 0035702821     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013366211927     Document Type: Article

References (32)

1. Hypertrophic cardiomyopathy: The importance of the extent of hypertrophy. A review
2. Left ventricular filling in hypertrophic cardiomyopathy: An angiographic study
3. Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: An echocardiographic study
4. Isovolumic relaxation period in hypertrophic cardiomyopathy
5. Hypertrophic cardiomyopathy: A 1987 view point
6. Muscular subaortic stenosis: Hemodynamic and clinical improvement after disopyramide
7. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration
8. Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration
9. Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy
10. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy
11. Class Ia antiarrhythmic drug cibenzoline: A new approach to the medical treatment of hypertrophic obstructive cardiomyopathy
12. An early systolic sound associated with mid ventricular obstruction in a patient with hypertrophic cardiomyopathy
13. Effect of disopyramide on left ventricular pressure gradient in hypertrophic obstructive cardiomyopathy in comparison with propranolol: A case report
14. Effect of cibenzoline on regional left ventricular function in patients with hypertrophic obstructive cardiomyopathy as assessed by ultrasonic integrated backscatter
15. Effect of acute administration of propranolol on ventricular function in hypertrophic obstructive cardiomyopathy measured by non-invasive techniques
16. Diastolic function in hypertrophic cardiomyopathy: Effects of propranolol and verapamil on diastolic stiffness
17. Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: An echocardiographic study
18. Comparative effects of calcium-channel blockers and beta-adrenergic blocker on early diastolic time intervals and A-wave ratio in patients with hypertrophic cardiomyopathy
19. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies
20. Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiographic measurements
21. Doppler estimation of left ventricular filling pressure in patients with hypertrophic cardiomyopathy
22. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function
23. Color M-mode Doppler flow propagation velocity is a preload insensitive index of left ventricular relaxation: Animal and human validation
24. Assessment of mitral annular dynamics during diastole by Doppler tissue imaging: Comparison with mitral Doppler inflow in subjects without heart disease and in patients with left ventricular hypertrophy
25. Intraventricular early diastolic filling during acute myocardial ischemia, assessment by multigated color m-mode Doppler echocardiography
26. Abnormalities of left ventricular filling in patients with coronary artery disease: Assessment by colour M-mode Doppler technique
27. Effects of cibenzoline, a novel antiarrhythmic drug, on action potential and transmembrane currents in frog atrial muscle
28. Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline
29. Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy
30. Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects
31. 2+ inward current by the class I antiarrhythmic agent, cibenzoline
32. 2+ channel inhibitory effects of cibenzoline with verapamil on guinea-pig heart